Page 24 - pesta2025_2

-pest-POSTEN Side 24

mellom medikamentene Cefalotin, Cefazolin, primary THAs in the Norwegian Arthroplasty
Cefuroksim, Kloksacillin eller Klindamycin (alle Register from 2005 to 2019. Acta Orthop.
med ulik halveringstid). 2021;92(2):208-14.
Artikkelforfatteren publiserte nylig en ny studie 8. Karlsen Ø E, Dale H, Furnes O, Eriksen-Volle
hvor fire forskjellige doseringer (hhv 1,2,3 og HM, Westberg M. Trends in surgical site
4 doser operasjonsdagen), og de fem hyppigst infection and periprosthetic joint infection
brukte typer antibiotika, med Cefazolin 4 after primary total hip arthroplasty in two
doser som referanse, ble studert. Vi fant at det national health registers 2013-2022. J Hosp
var trygt med en dose Cefazolin preoperativt, Infect. 2025;159:148-55.
sammenlignet med gjentatte doser som til nå har 9. Langvatn H, Bartz-Johannessen C, Schrama
vært praksis(12). Dette vil nå bli implementert JC, Hallan G, Furnes O, Lingaas E, et al.
i de nye reviderte nasjonale retningslinjene for Operating room ventilation-Validation of
antibiotikabruk i sykehus(13). reported data on 108 067 primary total hip
arthroplasties in the Norwegian Arthroplasty
Referanser Register. J Eval Clin Pract. 2020;26(3):1022-9.

1. Havelin LI, Engesaeter LB, Espehaug 10. Leta TH, Gjertsen JE, Dale H, Hallan G,
B, Furnes O, Lie SA, Vollset SE. The Lygre SHL, Fenstad AM, et al. Antibiotic-
Norwegian Arthroplasty Register: 11 years Loaded Bone Cement in Prevention of
and 73,000 arthroplasties. Acta Orthop Scand. Periprosthetic Joint Infections in Primary
2000;71(4):337-53. Total Knee Arthroplasty: A Register-based
Multicentre Randomised Controlled Non-
2. Register NA. Norwegian Arthroplasty Register inferiority Trial (ALBA trial). BMJ Open.
Annual Rapport 2024. 2024. 2021;11(1):e041096.
3. Dale H, Hallan G, Hallan G, Espehaug B, 11. Lutro O, Mo S, Tjørhom MB, Fenstad AM,
Havelin LI, Engesaeter LB. Increasing risk Leta TH, Bruun T, et al. How good are
of revision due to deep infection after hip surgeons at disclosing periprosthetic joint
arthroplasty. Acta Orthop. 2009;80(6):639-45. infection at the time of revision, based on
4. Dale H, Skråmm I, Løwer HL, Eriksen HM, pre- and intra-operative assessment? A study
Espehaug B, Furnes O, et al. Infection after on 16,922 primary total hip arthroplasties
primary hip arthroplasty: a comparison of reported to the Norwegian Arthroplasty
3 Norwegian health registers. Acta Orthop. Register. Acta Orthop. 2024;95:67-72.
2011;82(6):646-54. 12. Lutro O, Tjørhom MB, Leta TH, Gjertsen JE,
5. Dale H, Fenstad AM, Hallan G, Havelin LI, Hallan G, Bruun T, et al. How many doses
Furnes O, Overgaard S, et al. Increasing risk and what type of antibiotic should be used as
of prosthetic joint infection after total hip systemic antibiotic prophylaxis in primary hip
arthroplasty. Acta Orthop. 2012;83(5):449-58. and knee arthroplasty? A register-based study
on 301,204 primary total and hemi- hip and
6. Dale H, Fenstad AM, Hallan G, Overgaard total knee arthroplasties in Norway 2005-2023.
S, Pedersen AB, Hailer NP, et al. Increasing Acta Orthop. 2025;96:217-25.
risk of revision due to infection after primary
total hip arthroplasty: results from the Nordic 13. Norwegian Directorate of Health. Antibiotic
Arthroplasty Register Association. Acta prophylaxis in orthopedic surgery: Norwegian
Orthop. 2023;94:307-15. Directorate of Health; 2018 [Available from:
https://www.helsedirektoratet.no/retningslinjer/
7. Dale H, Hovding P, Tveit SM, Graff JB, antibiotika-i-sykehus/antibiotikaprofylakse-
Lutro O, Schrama JC, et al. Increasing but ved-kirurgi/ortopedisk-kirurgi#ortopedisk-
levelling out risk of revision due to infection kirurgi-med-leddproteser-forskningsgrunnlag.
after total hip arthroplasty: a study on 108,854